Livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanova's employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects¿ or "malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.
|
It was reported that the patient may have sleep apnea and would be observed to see if it improves.If it were to not improve, it was noted the patient would be referred for a newer vns model to allow day/night programming modes.The latest clinic notes then noted that the patient underwent a study that did not find any underlying sleep disorder; however, the patient is complaining of shortness of breath at night and is worried as it affects their sleep.It was indicated that vns was the likely explanation for this and the patient was referred for a battery replacement for a newer model with the day and night programming feature no known relevant surgical intervention has occurred to date.No other relevant information has been received to date.
|